Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 60 citing Desouza: Association of hypoglycemia and cardiac ischemia. (0.09 sec) 

Association between hyper-and hypoglycaemia and 2 year all-cause mortality risk …

- oxfordjournals.org
AM Svensson, DK McGuire, P Abrahamsson, … - European heart …, 2005 - Eur Soc Cardiology
Methods and results A total of 713 consecutive patients with diabetes were included. During
2 years of follow-up, 242 (34%) patients died. All analyses were retrospective using prospectively
collected clinical data. The primary study endpoint was 2 year all-cause mortality ...
Cited by 102 - Related articles - All 8 versions

The role of sulphonylureas in the management of type 2 diabetes mellitus

- adisonline.com [PDF] 
M Rendell - Drugs, 2004 - ingentaconnect.com
The sulphonylureas act by triggering insulin release from the pancreatic β cell. Abstract A specific
site on the adenosine triphosphate (ATP)-sensitive potassium channels is occupied by sulphonylureas
leading to closure of the potassium channels and subsequent opening of calcium ...
Cited by 87 - Related articles - BL Direct - All 7 versions

Hypoglycemia in type 2 diabetes

- diabetesjournals.org
NN Zammitt, BM Frier - Diabetes Care, 2005 - Am Diabetes Assoc
The importance of strict glycemic control to limit the risk of diabetic vascular complications is
indisputable, but many barriers obstruct its attainment. Hypoglycemia is recognized to be a major
limitation in achieving good control in type 1 diabetes (1) but has been considered to be a ...
Cited by 89 - Related articles - All 6 versions

A comparison of bedtime insulin glargine with bedtime neutral protamine hagedorn …


V Fonseca, DS Bell, S Berger, S Thomson, … - The American journal of …, 2004 - journals.lww.com
ABSTRACT: Background: Basal insulin is frequently ad- ministered once daily. This subgroup
analysis of a multi- center, randomized, parallel study compared insulin glargine (Lantus Aventis
Pharmaceuticals, Bridgewater, NJ) with neutral protamine Hagedorn (NPH) insulin in ...
Cited by 44 - Related articles - BL Direct - All 3 versions

Counterpoint: Inpatient Glucose Management


SE Inzucchi, J Rosenstock - Diabetes Care, 2005 - Am Diabetes Assoc
Recently, the attention of the diabetes community has shifted to glycemic management in the
inpatient setting, where there has been a rising chorus in support of stricter blood glucose
control. We applaud the spirit of the current American College of Endocrinology (ACE) ...
Cited by 32 - Related articles - All 4 versions

Role of insulin secretagogues and insulin sensitizing agents in the prevention of …

- rksoul.net [PDF] 
AA Jawa, VA Fonseca - Cardiology clinics, 2005 - Elsevier
Cardiovascular disease is the leading cause of death among patients who have diabetes
mellitus. Patients who have diabetes mellitus have a greatly increased relative risk of cardiovascular
disease when compared with patients who do not have diabetes mellitus [1]. Furthermore, ...
Cited by 20 - Related articles - All 4 versions

Perioperative glucose control in the diabetic or nondiabetic patient

- critcaremed.org
DD Smiley, GE Umpierrez - Southern Medical Journal, 2006 - journals.lww.com
Abstract: Patients with diabetes are more likely to undergo surgery than nondiabetics, and maintaining
glycemic control in subjects with diabetes can be challenging during the perioperative
period. Surgery in diabetic patients is associated with longer hospital stay, higher health ...
Cited by 21 - Related articles - BL Direct - All 14 versions

Efficacy of continuous glucose monitoring system (CGMS) to detect postprandial …


FFR Maia, LR Araújo - Diabetes research and clinical practice, 2007 - Elsevier
The mean capillary glucose values were 191.8 ± 46.2 mg/dl versus 190.9 ± 42.1 mg/dl by CGMS
sensor, with no statistical difference by T-test (T = −0.6; p = 0.79). The CGMS was significantly
more efficient in detection of glycemic excursion than CG (p = 0.001). The postprandial ...
Cited by 20 - Related articles - All 12 versions

The impact of antidiabetic therapies on cardiovascular disease


B Panunti, B Kunhiraman, V Fonseca - Current atherosclerosis reports, 2005 - Springer
Introduction Cardiovascular disease (CVD), including coronary artery disease (CAD), peripheral
arterial disease (PAD), and cerebrovascular disease, disproportionately affects people with diabetes
and is a leading cause of death. There is a significantly increased risk of CAD with type 2 ...
Cited by 18 - Related articles - All 3 versions

Implantable glucose sensors for diabetes monitoring


E Renard - Minimally Invasive Therapy and Allied Technologies, 2004 - ingentaconnect.com
The development of glucose sensors for clinical use is driven by the aim of blood glucose normalization
in diabetic patients, and the detection of blood glucose impairment in nondiabetic subjects submitted
to critical conditions. Currently available devices for continuous glucose monitoring are ...
Cited by 13 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google